Irada Khalilova


PUBLICATIONS AND PROJECT TITLES:


Refereed Journal Papers: 

Dickerhof N, Turner R, Khalilova I, Fantino E, Sly PD, Kettle AJ, Arest CF. (2017). Oxidized glutathione and uric acid as biomarkers of early cystic fibrosis lung disease.  J Cyst Fibros. 16(2):214-221. doi: 10.1016/j.jcf.2016.10.012

Seidel A, Parker H, Turner R, Dickerhof N, Khalilova IS, Wilbanks SM, Kettle AJ, Jameson  GNL. (2014). Uric acid and thiocyanate as competing substrates of lactoperoxidase.  J Biological Chemistry, 289(32):21937-21949. doi: 10.1074/jbc.M113.544957

Stamp LK, Turner R, Khalilova IS, Zhang M, Drake J, Forbes LV, Kettle AJ. (2014). Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemia. J. Rheumatology (Oxford), pp. 266-273. doi: 10.1093/rheumatology/keu218

Kettle AJ, Turner R, Gangell CL, Khalilova IS, Harwood DT, Chapman AL, Winterbourn CC, Sly PD. (2014). Oxidation contributes to low glutathione in the airways of children with cystic fibrosis. European Respiratory Journal, 44:122-129. doi: 10.1183/09031936.00170213 

Kettle AJ, Albrett AM, Chapman AL, Dickerhof N, Forbes LV, Khalilova I, Turner R. (2014). Measuring chlorine bleach in biology and medicine. Biochimica et Biophysica Acta, vol. 1840, issue 2, pp. 781-793. doi: 10.1016/j.bbagen.2013.07.004

Chapman AL, Mocatta TJ, Shiva S, Seidel A, Chen B, Khalilova I, Paumann-Page ME, Jameson GN, Winterbourn CC, Kettle AJ.(2013). Ceruloplasminin is an endogenous inhibitor of myeloperoxidase. J. Biological Chemistry, 288:6465-6477.   doi: 10.1074/jbc.M112.418970

Forbes LV, Paul G Furtmüller PG, Khalilova I, Turner R, Obinger C, Kettle AJ. (2012). Isoniazid as a substrate and inhibitor of myeloperoxidase: identification of amine adducts and the influence of superoxide dismutase on their formation. J. Biochemical pharmacology, 84(7): pp.949-60. doi: 10.1016/j.bcp.2012.07.020

Stamp LK, Khalilova I, Tarr JM, Senthilmohan R, Turner R,  Haigh RC,  Winyard PG, Kettle AJ. (2012). Myeloperoxidase and oxidative stress in rheumatoid arthritis.  J.Rheumatology (Oxford, England), 51(10): pp. 1796-803. doi: 10.1093/rheumatology/kes193

Orudzhev AG, Guseĭnova EE, Khalilova IS, Dzhavadov SA. (2003). Assessment of endogenous intoxication and thrombocyte functions in beta-thalassemia. J.Clinical Laboratory Diagnostics, (3):39-41. Russia, ISSN 0869-2084. PMID:12715396

Khalilova IS. (2002). Estimation of the proteolytic system in blood during beta thalassemia. J.Actual Problems of Hematology and Transfusiology, pp.81-85, Azerbaijan.

Khalilova IS, Orujov AG, Huseynova EE, Alekperova GA. (2002). Immunobiological violations of phormennous elements of blood during beta thalassemia. Journal of Azerbaijan Biophysical Association, pp.215-223, Azerbaijan.

Guseinova EE, Khalilova IS, Dzhavadov SA. (2002). Proteolytic blood system in hemoglobinophaty. J. Haematology and Transfusiology, vol.47, N. 4, pp.33-35, Russia ISSN 0234-5730.

Khalilova IS, Jokharidze TZ, Gelfgat EB, Javadov SA. (1994). Development of experimental model of the immunosorbent for removal antibodies to insulin. J. Immunology, N.3, pp.58-61, Russia, ISSN 0206-4952.

Khalilova IS, Jokharidze TZ, Javadov SA.(1993). Research on possibilities for removing antibodies to insulin from circulation. In the book: Oncology and related sciences nowadays, pp.38-39, Baku.

Khalilova IS, Javadov SA. (1993). Correlation between main parameters of immune status and levels of anti-insulin antibodies in patients with diabetes mellitus type I and II. In the book: Oncology and related sciences nowadays, pp.36-38, Baku.

Khalilova IS,  Jokharidze TZ, Gelfgat EB, Javadov SA. (1993). Evaluation the immune status in patients with diabetes mellitus types I and II. Azerbaijan Medical Journal, N.7-8, pp.38-41, Baku, ISSN 0005-2523.

Khalilova IS, Gelfgat EB,  Jokharidze TZ, Javadov SA. (1993). Main parameters of the immune system and levels of insulin antibodies during diabetes mellitus. J. Immunology, N.3, pp.46-48, Russia, ISSN 0206-4952.

Khalilova IS, Jokharidze TZ, Gelfgat EB,  Javadov SA. (1992). Immunosorbent preparation for the anti-insulin antibodies removal from the insulin-resistant diabetic patients’ plasma. Azerbaijan Medical Journal, N.7-8, pp.12-16, Baku ISSN 0005-2523.

Khalilova IS, Jokharidze TZ, Javadov SA. (1991). Elaboration of experimental model of immunosorbent for removing antibodies to insulin from circulation. In Publications of Transactions of the National Academy of Sciences of (biological sciences series), pp.5-8, Baku.

 

Refereed Conference Papers and Abstracts:

 

Stamp LK, Khalilova I, Turner R, Chapman P, O’Donnell J, Kettle A. (2014).  Oxidative Stress from Use of Allopurinol - Is There a Reason for Patients with Gout to Take Vitamin C? American College of Rheumatology/Association of Rheumatology Health professionals, ACR/ARHP ANNUAL MEETING.

Stamp LK, Khalilova I, Zhang M, Turner R, Kettle A. (2012). Oxidation of urate to allantoin by myeloperoxidase in gout. Arthritis & Rheumatism, vol.64, November 9-14, Suppl 10:1903, DOI: 10.1002/art.39635.

Kettle AJ, Turner R, Gandell CL, Khalilova I, Harwood DT, Chapman AL, Winterbourn CC, Sly DT. (2011). Oxidation of glutathione in the airways of young children with cystic fibrosis. American Thoracic Society International Conference Abstracts - B33. Oxidants, Oxidases  and Redox Regulation of Lung Disease, A2793, 10.1164/ajrccm-conference. 183.1_MeetingAbstracts.A2793.

Stamp LK, Khalilova I, Kettle A. (2010). Acute Gout Results In Increased Plasma Myeloperoxidase: A Potential Mechanism for Increase Cardiovascular Risk? Supplement, Abstracts of the American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting Atlanta, Georgia. DOI: 10.1002/art.28638

Khalilova I, Mocatta T, Marshall C, McClean D, Winterbourn C, Kettle A. (2009). Detection of active and inactive myeloperoxidase in plasma, 5th Joint Meeting of the Societies for Free Radical Research Australasia and Japan Mutagenesis and Experimental Pathology Society of Australia, Sydneyp.147-148.

Gurbanova MM, Khalilova IS. (2001). Comparative research of the basic parameters of cellular and humoral immunity in patients with the posttraumatic haemorrhages eyes during Perftoran treatment.Proceedings of the International Scientific Conference “Family Health in XXI Century”, pp.42-43, Perm (Russia)-Dubai (UAE).

Khalilova IS, Huseynova EE. (2002). Study of the thrombocytes and homeostasis during beta thalassemia. Proceedings of the International Scientific Conference “Family Health in XXI Century,”pp.149-150, Perm (Russia)-Dubai (UAE).

Orujov AG, Huseynova EE, Khalilova IS. (2001). The endogenous intoxication state during beta thalassemia. Proceedings of the I Conference of Azerbaijan Society of Biochemists and Molecular Biologists, pp.8-9, Baku.

Huseynova EE, Khalilova IS. (2000). Interrelation of the protective systems and endogenous intoxication in patients with hemoglobinopathy. Proceedings of the Scientific Conference Dedicated to 100-years Anniversary of A.S.Hasanov, p.62, Baku.

Javadov SA, Orujov AH, Khalilova IS. (2000). Study of platelet proteins and antibodies during beta thalassemia. Proceedings of the Scientific Conference Dedicated to 100-years Anniversary of A.S.Hasanov, p.57, Baku.

Huseynova EE, Khalilova IS, Javadov SA. (2000). The endogenous intoxication state and sorption ability of erythrocytes in children’s blood during sickle cell anaemia. Proceeding of the VI Congress of International Society o Immunorehabilitation, J.on Immunorehabilitation, v.2, N.2, p.48, Israel, ISSN 1562-3629.

Orujov AH, Khalilova IS. (1999). Definition of different forms of immune complexes and platelet antibodies in children’s blood with beta thalassemia. Proceedings of the II Congress of Azerbaijan Society of Physiologists, p.151, Baku. 

Huseynova EE, Khalilova IS. (1999). Main parameters of humoral immunity in children with beta thalassemia. Proceedings of the I National Congress of Azerbaijan Society of Allergology, Immunology and Immunorehabilitation, pp.130-131, Baku.

Orujov AH, Khalilova IS. (1999). Antibodies to thrombocytes in children with beta thalassemia. Proceedings of the I National Congress of Azerbaijan Society of Allergology, Immunology and Immunorehabilitation, p.214, Baku. 

Orujov AH, Khalilova IS, Javadov SA. (1999). The content of immune complexes and platelet antibodies in patients with beta thalassemia.  Proceedings of the Joint Meeting of Pediatric Assembly, European Respiratory Society and European Society of Pediatric Allergy and Clinical Immunology, Allergy: European Journal of Allergy & Clinical Immunology, Suppl. 51, v.54, p.1, Berlin, Germany, ISSN 0105-4538. 

Orujov AH, Khalilova IS, Javadov SA. (1999). Study of humoral immunity in children with beta thalassemia. Proceedings of the V Congress of International Society on Immunorehabilitation In: International J.on Immunorehabilitation, N.12, p.131, Spain, ISSN 1562-3629.

Javadov SA, Khalilova IS. (1998). Heart performance and immunological parameters of blood in patients with diabetic cardiomyopathy. Proceedings of the VII International Symposium on Insulin Receptors and Insulin Action: Molecular and Clinical Aspects, p.217, Jerusalem, Israel.

Khalilova IS, Jokharidze TZ, Javadov SA. (1996). Content of minor, medium and large immune complexes, including immune globulins A, M, G classes in children with homozygous type of beta thalassemia. Proceedings of the III Congress of Biochemists of Azerbaijan, Baku

Khalilova IS. (1995). An experimental model approbation of immune sorbents based on CNBr-sepharose. Proceedings of the Scientific Conference of Azerbaijan Medical University, Baku.

Javadov SA, Khalilova IS. (1994) Investigation of correlation between main parameters of immune status and levels of insulin antibodies in patients with I and II types of diabetes mellitus.Proceedings of the Annual Conference of Azerbaijan Medical University, pp.145-146.

Khalilova IS, Javadov SA. (1994) Study of possibility for the insulin antibodies removal from circulation. Proceedings of the Annual Conference of Azerbaijan Medical University, pp.146-147.

Gelfgat EB, Jokharidze TZ,  Khalilova IS, Javadov SA. (1990). Comparative studies of binding capability of sepharose and cellulose while preparing immune sorbents for removing antibodies to insulin. Proceedings of the I Conference of Azerbaijan Biochemical Society, p.51.

 

Conference Contribution - Verbal presentation and other Conference outputs

 

Khalilova IS, Dickerhof N, Mocatta T, Kettle AJ. (2013). Pro-myeloperoxidase is present in circulation and a potential participant in cardiovascular disease. Redox Conference of the Queenstown Molecular Biology Meeting Society. Queenstown, New Zealand. 

Khalilova IS, Dickerhof N, Mocatta T, Kettle AJ. (2012). Detection of pro-myeloperoxidase in circulation. Oxygen Theme Meeting, University of Otago, Dunedin, New Zealand.

Khalilova I, Chambers ST, Murdoch DR, Kettle AJ. (2010). Measurement of myeloperoxidase in urine for the detection of urinary tract infections. 19th Annual Conference of the Societies for Free Radical Research AustralasiaAkaroa, New Zealand.